Kenvue Inc. Chief Scientific Officer Disposes Holdings in Merger with Kimberly-Clark

Executive Summary

On November 2, 2026, Caroline Tillett, Chief Scientific Officer of Kenvue Inc. ($KVUE), disposed of her entire beneficial holding of 77,709 shares of common stock, along with all outstanding stock options, restricted stock units (RSUs), and performance stock units (PSUs), pursuant to the merger between Kenvue Inc. and Kimberly-Clark Corporation ("K-C"). Following these transactions, Dr. Tillett holds zero shares of Kenvue Inc., and Section 16 reporting obligations have ceased.

Transaction & Merger Details

• Merger Terms: Each share of Kenvue Common Stock was exchanged for 0.14625 shares of Kimberly-Clark common stock and $3.50 in cash.
• Common Stock Disposed: 77,709 shares directly owned.
• Derivative Awards Treatment:
  • Options, RSUs, and PSUs were assumed and converted into corresponding equity awards of Kimberly-Clark Common Stock based on the contractual Equity Award Exchange Ratio formula.
  • PSUs were adjusted based on Committee-determined achievement percentages prior to conversion.

Market & Trading Significance

This transaction carries Low trading significance as an indicator of corporate health or insider sentiment. It represents an involuntary, automatic disposition and rollover of equity resulting from the closing of the previously agreed-upon acquisition of Kenvue Inc. by Kimberly-Clark Corporation rather than discretionary open-market buying or selling.